| Name | Title | Type |
|---|---|---|
| Derrick Lovett | President/CEO | Auditee |
| Frank Buss II | Partner | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 365662 | 2024 | 2025-09-05 | Novogradac & Company LLP | $9.28M |
| 323019 | 2023 | 2024-09-30 | Novogradac & Company LLP | $9.36M |
| 4423 | 2022 | 2023-11-28 | Novogradac & Company LLP | $9.46M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 365662 | 2024 | 2025-09-05 | 1152098 | 2024-001 | Material Weakness | - | B |
| 365662 | 2024 | 2025-09-05 | 1152097 | 2024-001 | Material Weakness | - | B |
| 365662 | 2024 | 2025-09-05 | 575656 | 2024-001 | Material Weakness | - | B |
| 365662 | 2024 | 2025-09-05 | 575655 | 2024-001 | Material Weakness | - | B |
| 323019 | 2023 | 2024-09-30 | 1076620 | 2023-002 | Significant Deficiency | - | N |
| 323019 | 2023 | 2024-09-30 | 1076619 | 2023-002 | Significant Deficiency | - | N |
| 323019 | 2023 | 2024-09-30 | 500178 | 2023-002 | Significant Deficiency | - | N |
| 323019 | 2023 | 2024-09-30 | 500177 | 2023-002 | Significant Deficiency | - | N |
| 4423 | 2022 | 2023-11-28 | 579062 | 2022-003 | Significant Deficiency | - | N |
| 4423 | 2022 | 2023-11-28 | 579061 | 2022-002 | Significant Deficiency | Yes | N |
| 4423 | 2022 | 2023-11-28 | 579060 | 2022-001 | Significant Deficiency | Yes | L |
| 4423 | 2022 | 2023-11-28 | 579059 | 2022-003 | Significant Deficiency | - | N |
| 4423 | 2022 | 2023-11-28 | 579058 | 2022-002 | Significant Deficiency | Yes | N |
| 4423 | 2022 | 2023-11-28 | 579057 | 2022-001 | Significant Deficiency | Yes | L |
| 4423 | 2022 | 2023-11-28 | 2620 | 2022-003 | Significant Deficiency | - | N |
| 4423 | 2022 | 2023-11-28 | 2619 | 2022-002 | Significant Deficiency | Yes | N |
| 4423 | 2022 | 2023-11-28 | 2618 | 2022-001 | Significant Deficiency | Yes | L |
| 4423 | 2022 | 2023-11-28 | 2617 | 2022-003 | Significant Deficiency | - | N |
| 4423 | 2022 | 2023-11-28 | 2616 | 2022-002 | Significant Deficiency | Yes | N |
| 4423 | 2022 | 2023-11-28 | 2615 | 2022-001 | Significant Deficiency | Yes | L |